Ticker brief

BEAM BEAM THERAPEUTICS INC

Consumer, Non-cyclical · Biotechnology

last close
$24.05
1 day
-2.1%
14 days
-6.4%
mkt cap
$3.6B
signals 14d
9
authors 14d
8
crowd 14d
+1.1σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d75% mid · 32 pctile own 1yIV/HV 1.28×
Skew — 25Δ RR 30d+0.021 68 pctile own 1ybalanced vs own range
Net dealer OI (NDOI)+0.51 elevated5-session Δ -0.34 (as of 2026-07-16)
OI alarmquietlast alarm 2026-05-28 (z=2.7)
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-13 · now +0.54 (−1 bearish … +1 bullish)
Who spoke8
authorgradetrader scoresignalsmean sent
@SandmanMarketsC+0.582+0.75
@nanalyzetweetsB+5.591+0.20
@CryptoPatelC-0.011+0.75
@RosannaInvestsB-2.891+0.40
@AlexsOptionsC-1.181-0.30
@MMMTwealthA-0.391+0.40
@cnfinancewatchB-1.231+0.45
@Stockspy1C-1.441+0.54
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-13@Stockspy1+0.54Open a first-tranche BEAM short at $24.50 as biotech sell signals build. — Explicit new BEAM short with entry price, sell signal and sector thesis; FCEL is a bearish comparison.-1.6%
2026-10-12@cnfinancewatch+0.45Maps four listed gene-editing companies to distinct technology platforms and leadership claims.-4.3%
2026-10-09@SandmanMarkets+0.80Buy BEAM from the alert after its OBV breakout — Explicit buy recommendation citing a perfect historical record and OBV breakout-6.4%
2026-10-09@SandmanMarkets+0.70Buy LPX, BEAM, CCC and TWST; watch CRNT and HXL — Publishes explicit buy and watch lists; ticker cap retains buys and first two watches-6.4%
2026-10-09@MMMTwealth+0.40Presents a multi-sector basket spanning AI biology, crypto, commodities, optics and power.-6.4%
2026-10-06@AlexsOptions-0.30Cites simultaneous technical breaks across biotechnology names as evidence.-4.7%
2026-10-06@RosannaInvests+0.40Playfully promotes a Bitcoin-and-biotech basket containing four named securities.-4.7%
2026-10-04@CryptoPatel+0.75Will seek a long entry at $0.0017–$0.0014 after a confirmed close above $0.002173. — Conditional long plan includes confirmation, entry zone, five targets, and invalidation below $0.001275.-1.8%
2026-10-03@nanalyzetweets+0.20Presents genomics stocks to consider across genetic testing and gene-editing categories.-1.8%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.